Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
about
Bipolar disorder in childrenPharmacotherapy of bipolar disorder in children and adolescents: an updateTreatment of Pediatric Bipolar Disorder: A ReviewOlanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patientsDouble-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorderPediatric bipolar disorder: evidence-based psychopharmacological treatments.Child psychopharmacology: Is it more similar than different from adult psychopharmacology?Psychopharmacology of pediatric bipolar disorder.Practitioner review: Long-term pharmacological treatment of pediatric bipolar disorder.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.Is There a Bipolar Prodrome Among Children and Adolescents?Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Pharmacological Treatment of Anorexia Nervosa: A Retrospective Study in Preadolescents and Adolescents
P2860
Q21284506-0114F45B-8364-4E3D-A10E-D00F4A99487DQ27027052-144B5228-BF06-41A9-AEBD-C733205F2F5AQ34206467-0EE01E6D-AF5F-4AEE-8C98-A749B80B73AFQ34329829-DADD53A4-83CC-4BCC-8BF7-73DBEF38EF08Q34455825-FA2AD137-FDAF-442B-ABCB-1820938C1B36Q35978923-70D62545-273D-42CC-8AF7-B4779BC0C9E4Q36706242-26A475F4-87F6-472F-A480-EF907AC03EC5Q36729682-DE76F93F-1897-4EDC-8BE1-B1A6B2844C0FQ37183308-19C4E130-DE97-4BD2-ABDD-7991BEFE2C02Q37768441-53E527A3-648A-42CB-836C-B76339A777FEQ38218213-1A08E547-A0DB-4E2B-8537-965ADE5569F8Q39285492-C199E964-23AD-42C6-9A2F-5B3FBB997FE7Q46808074-9766AB08-1A76-4076-85CC-04BE2DAEF453Q48063620-3E6C2A68-8DAA-4E75-9EC9-FBD7F747E48DQ52656684-5D9B7B34-1CBD-485C-9D8A-068EE4AF6555Q57899051-FEC3628F-1AA6-4C57-998D-61BBB8248F1D
P2860
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@en
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@nl
type
label
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@en
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@nl
prefLabel
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@en
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@nl
P2093
P2860
P1433
P1476
Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
@en
P2093
David B Henry
Julie A Carbray
Mani N Pavuluri
Michael W Naylor
Philip G Janicak
P2860
P304
P356
10.1111/J.1399-5618.2005.00204.X
P577
2005-06-01T00:00:00Z